How to Build Meaningful Relationships in a Virtual Workplace

 

The coronavirus pandemic continues to transform the way people live and work, including the way professionals build relationships with their colleagues in a virtual setting.

With a proprietary relationship-building technique called the 5-Star Approach, Tyler Small shows that creating meaningful relationships online is possible — and even easy.

He posits that people who want to build relationships with their coworkers must invent new ways of meeting or running into people. Unlike real life, where you can organically strike up a conversation with others at the printer or water cooler, virtual workplaces don’t have these meetup spots.

Small suggests three ways to connect with virtual coworkers:

  • Once they go on a break, ask a colleague if they have a minute to chat
  • Before a meeting starts, see if a coworker would be interested in a one-on-one call if time permits after the meeting
  • Create a schedule to catch up with certain people during the week

He also mentioned that the best way to meet with someone virtually is through a face-to-face conversation where you can see each other on the screen, as this is the most similar to conversations you’d have in real life. In fact, Small noticed a huge difference in the cultures of companies that work mostly face-to-face and those that work mostly over the phone.

When it comes to improving on your current relationships, Small encourages seeking feedback from the people you interact with. Ask them, “From 1-5, how would you rate our relationship? What can I do to make it better?”

Questions like these give you a baseline to work with, and shows you the direction you need to take moving forward. Once you begin the 5-Star Approach with someone, they will begin to reciprocate your efforts — a phenomenon called the law of reciprocation.

Stay Tuned for a New Episode Every Monday and Thursday!

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More